
SternAegis
Description
SternAegis Ventures operates as the dedicated venture capital arm of Aegis Capital Corp., a full-service broker-dealer based in New York. Unlike traditional venture capital funds that deploy capital from a fixed pool, SternAegis Ventures functions primarily as a division within Aegis Capital Corp. that specializes in facilitating private placements. Their strategic focus is on late-stage private equity and venture capital investments, targeting companies within the technology, telecom, media, and internet sectors, as well as broader emerging growth industries. This unique structure allows them to leverage the extensive network and financial capabilities of a broker-dealer to connect promising companies with a diverse pool of investors.
The core of SternAegis Ventures' model is to act as an intermediary, assisting growth-stage and pre-IPO companies in raising substantial capital. They do not manage a dedicated venture fund from which they write direct "first cheques" in the conventional sense. Instead, their expertise lies in structuring and executing private placements, bringing together companies seeking significant funding with institutional and high-net-worth investors. This approach distinguishes them from typical early-stage VC firms, positioning them more akin to a merchant bank or an investment banking division focused on private capital formation.
Their involvement typically centers on companies that have already achieved considerable traction and are seeking substantial growth capital, often in the tens of millions of dollars or more. For instance, SternAegis Ventures was involved in a $125 million private placement for FuboTV, demonstrating their capacity to facilitate large-scale funding rounds for companies nearing public market readiness. Other notable engagements include their participation in pre-IPO placements for companies like DraftKings and Wheels Up, further underscoring their focus on later-stage, high-growth opportunities.
Given their operational model as a facilitator of private placements rather than a direct fund investor, the concept of a "typical first cheque size" for SternAegis Ventures' own capital deployment is not applicable. Their role is to enable and manage the flow of capital from various investors into these late-stage private companies, making it challenging to assign specific minimum or maximum investment figures for their own direct participation, which may be negligible or non-existent as a fund.
Investor Profile
SternAegis has backed more than 36 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 6% of its total and boasts 15 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity, Series A rounds (top funding stages).
- Majority of deals are located in United States, Israel, India.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series Unknown (58%)
- Post Ipo Equity (19%)
- Series A (6%)
- Convertible Note (6%)
- Series B (3%)
- Angel (3%)
- Undisclosed (3%)
- Series D (3%)
Country Focus
- United States (89%)
- Israel (6%)
- India (3%)
- Canada (3%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Medical Device
- Health Diagnostics
- Manufacturing
- Software
- Consumer Goods
- Food And Beverage
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.